Siemens Healthineers AG

Research Siemens Healthineers AG (SHL.DE) on Bullrun: market cap EUR 42.37B, P/E 19.2, dividend yield 2.5%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 42.37B; P/E is 19.2; dividend yield is 2.5%.

Peer valuation comparison

Latest P/E is 19.22x versus a Healthcare sector median of 24.6x (21.9% below).

Latest dividend yield is 2.51% versus a Healthcare sector median of 1.84% (36.4% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-04EUR 42.37B19.22.6%1

Dividend history

Latest trailing dividend snapshot: annual dividend/share 1 EUR, yield 2.5%.

About Siemens Healthineers AG

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound systems;

ETFs that hold Siemens Healthineers AG

Siemens Healthineers AG is one of the ten largest holdings of 3 ETFs that investors in Europe can buy, most traded first:

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Siemens Healthineers AG's market cap?

Siemens Healthineers AG's market capitalization is EUR 42.37B.

What is Siemens Healthineers AG's P/E ratio?

Siemens Healthineers AG's price-to-earnings (P/E) ratio is 19.2.

Does Siemens Healthineers AG pay a dividend?

Siemens Healthineers AG has a dividend yield of 2.5%.

What does Siemens Healthineers AG do?

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies.